News | November 08, 2024
Neuland Laboratories Q2 FY25 consolidated PAT falls to Rs. 32.84 Cr
Neuland Laboratories has reported total income of Rs. 315.17 crores during the period ended September 30, 2024
Neuland Laboratories has reported total income of Rs. 315.17 crores during the period ended September 30, 2024
The centre is equipped with the most modern tools and provides an environment soothing for all professionals and patients
The group plans to establish new hospitals in Kerala developing large health cities in Kochi and Kozhikode
The recognition from Malaysia's NPRA, a member of PIC/S, opens doors to new global business opportunities
Dr. Reddy's Laboratories has reported total income of Rs. 8,016.2 crores during the period ended September 30, 2024
Partnership to Combine AbbVie's Oncology Expertise with EvolveImmune's Proprietary EVOLVE T-Cell Engager Platform to Develop Novel Multispecific Therapeutic Antibodies for Cancer
Commercial license to Synaffix technologies follows a series of successful initial preclinical proof of concept studies
The company has reported total income of Rs. 1,465.49 crores during the period ended September 30, 2024
The partnership emphasises the introduction of renewable, bio-based materials into existing plastic applications to help reduce fossil resource dependency
Lupin's R&D teams are working on products with a near-zero global warming potential propellant
Subscribe To Our Newsletter & Stay Updated
